Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1800020177Phase 4Not yet recruiting
Phase 4, randomised trial of Xiaoer Jinqiao granules and oseltamivir in influenza (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Clinical recovery time. Planned start Dec 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1800020177.